Yoshihiro Hayakawa Selected Research

Yoshihiro Hayakawa Research Topics

Disease

91	Neoplasms (Cancer) 01/2024 - 01/2002
36	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2003
20	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2004
12	Melanoma (Melanoma, Malignant) 08/2022 - 11/2005
12	Bites and Stings (Sting) 08/2022 - 02/2011
11	Lung Neoplasms (Lung Cancer) 04/2024 - 12/2013
10	Infections 01/2022 - 08/2003
5	Inflammation (Inflammations) 09/2023 - 12/2004
5	Lymphoma (Lymphomas) 01/2018 - 01/2004
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 07/2014
4	Sarcoma (Soft Tissue Sarcoma) 06/2007 - 08/2003
3	Autoimmune Diseases (Autoimmune Disease) 06/2018 - 08/2003
3	Carcinoma (Carcinomatosis) 01/2017 - 08/2003
3	Bacterial Infections (Bacterial Infection) 04/2015 - 08/2008
3	Carcinogenesis 09/2005 - 08/2003
2	Experimental Melanoma 08/2023 - 01/2018
2	Neuroblastoma 06/2022 - 04/2005
2	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 10/2004
2	Necrosis 12/2020 - 10/2019
2	Communicable Diseases (Infectious Diseases) 06/2018 - 08/2008
2	Fibrosarcoma 01/2017 - 09/2005
2	Obesity 01/2015 - 01/2010
2	Staphylococcal Infections 07/2009 - 02/2007
2	Mastitis 08/2005 - 03/2005

Drug/Important Bio-Agent (IBA)

23	LigandsIBA 12/2021 - 01/2002
14	bis(3',5')-cyclic diguanylic acidIBA 10/2015 - 03/2005
13	CytokinesIBA 06/2018 - 10/2004
12	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2003
12	InterferonsIBA 08/2022 - 01/2002
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2013 - 01/2002
9	PerforinIBA 01/2009 - 11/2002
8	Interleukin-12 (IL 12)IBA 09/2014 - 04/2002
7	alpha-galactosylceramideIBA 12/2005 - 04/2002
6	DNA (Deoxyribonucleic Acid)IBA 06/2014 - 02/2011
5	Phosphotransferases (Kinase)IBA 01/2023 - 02/2009
5	AntigensIBA 06/2020 - 06/2014
5	MethylcholanthreneIBA 06/2007 - 01/2002
4	Monoclonal AntibodiesIBA 08/2023 - 01/2002
4	Peptides (Polypeptides)IBA 10/2022 - 11/2005
4	Indicators and Reagents (Reagents)IBA 11/2020 - 06/2014
4	PhytochemicalsIBA 01/2020 - 11/2014
4	TNF-Related Apoptosis-Inducing LigandIBA 09/2013 - 01/2003
4	interleukin-21 (interleukin 21)IBA 05/2006 - 02/2004
3	SpectrinIBA 04/2024 - 06/2023
3	Calmodulin (Calcium-Dependent Activator Protein)IBA 04/2024 - 06/2023
3	Lipid NanoparticlesIBA 08/2022 - 01/2021
3	NF-kappa B (NF-kB)IBA 09/2021 - 01/2010
3	InterleukinsIBA 01/2021 - 11/2004
3	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2020 - 01/2017
3	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 04/2015
3	hirsutineIBA 07/2016 - 11/2014
3	Interferon Type IIBA 10/2015 - 02/2011
3	Histocompatibility Antigens Class IIBA 06/2012 - 01/2006
3	AntibodiesIBA 05/2010 - 01/2003
3	Vaccine AdjuvantsIBA 07/2009 - 10/2007
3	NK Cell Lectin-Like Receptor Subfamily KIBA 09/2005 - 11/2002
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2023 - 01/2017
2	Imiquimod (Aldara)FDA LinkGeneric 09/2023 - 04/2021
2	OvalbuminIBA 08/2023 - 11/2005
2	Matrix Metalloproteinases (MMPs)IBA 06/2023 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2023 - 01/2018
2	Chimeric Antigen ReceptorsIBA 01/2023 - 10/2022
2	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 10/2019
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2022 - 11/2005
2	AlkaloidsIBA 06/2022 - 07/2016
2	LuciferasesIBA 01/2022 - 04/2017
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2021 - 01/2020
2	Neoplasm Antigens (Tumor Antigens)IBA 09/2021 - 06/2020
2	MAP Kinase Kinase Kinase 5IBA 04/2021 - 12/2017
2	Interferon-gamma (Interferon, gamma)IBA 04/2021 - 11/2005
2	UbiquitinIBA 11/2020 - 04/2018
2	Deubiquitinating EnzymesIBA 11/2020 - 04/2018
2	Thalidomide (Thalomid)FDA Link 08/2020 - 08/2007
2	CarcinogensIBA 11/2019 - 01/2002
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2018 - 01/2013
2	Aldo-Keto ReductasesIBA 01/2018 - 10/2017
2	BerberineIBA 07/2017 - 09/2013
2	Connective Tissue Growth FactorIBA 10/2016 - 01/2016
2	Amino Acids FDA Link 01/2016 - 11/2005
2	Tyrosine Kinase InhibitorsIBA 01/2016 - 07/2014
2	Gefitinib (Iressa)FDA Link 01/2016 - 07/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2016 - 07/2014
2	YSK05IBA 10/2015 - 06/2014
2	Liposomes (Liposome)IBA 10/2015 - 06/2014
2	SurvivinIBA 09/2014 - 08/2014
2	Nucleic AcidsIBA 11/2012 - 09/2011
2	LectinsIBA 10/2011 - 11/2004
2	NucleotidesIBA 09/2011 - 02/2011
2	N,N'- dipyridoxylethylenediamine- N,N'- diacetic acid (PLED)IBA 08/2010 - 02/2009
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 05/2010 - 02/2004
2	Fas Ligand Protein (Fas Ligand)IBA 01/2009 - 11/2004
2	Immunologic Factors (Immunomodulators)IBA 08/2008 - 10/2007
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2005 - 01/2004
2	GpGpIBA 08/2005 - 04/2005
2	Anti-Infective Agents (Microbicides)IBA 04/2005 - 03/2005
2	Interleukin-18 (Interleukin 18)IBA 11/2004 - 03/2004

Therapy/Procedure

26	Therapeutics 01/2023 - 11/2002
21	Immunotherapy 09/2023 - 04/2002
7	Drug Therapy (Chemotherapy) 01/2024 - 01/2013
2	Traditional Medicine (Folk Remedies) 04/2021 - 12/2013